BeiGene

Sustainability Report and Carbon Intensity Rankings

Is BeiGene doing their part?

Their DitchCarbon score is 40

BeiGene has a DitchCarbon Score of 40 out of 100, indicating moderate performance in sustainability practices. This score reflects a certain level of carbon intensity in the company’s operations. There is room for improvement for BeiGene to reduce its carbon intensity and enhance its environmental impact.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

BeiGene is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Unknown

High

Very high

BeiGene, located in China, operates in a region with a certain carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon intensity, affecting its environmental impact.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on BeiGene

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

1.29%

...this company is doing 1.29% worse in emissions than the industry average.

BeiGene, Ltd., founded in 2010, is a biotechnology company operating in the pharmaceutical industry with a focus on developing cancer therapeutics. Headquartered in Cambridge, Massachusetts, the company has expanded its presence to mainland China, other parts of the United States, and Australia. BeiGene offers a range of services including the development of novel oral small molecules and monoclonal antibodies designed to treat cancer effectively.

Compare BeiGene with other companies in the same industry –>

emission intelligence's platform recommendations for BeiGene

BeiGene could reduce its emissions by transitioning to renewable energy sources for all purchased electricity, heat, steam, and cooling, which could potentially lower its emissions by 30%.

Bad news, BeiGene hasn't committed to SBTi goals yet

BeiGene has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

BeiGene

Sustainability Report and Carbon Intensity Rankings

Is BeiGene doing their part?

Their DitchCarbon score is 40

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Unknown

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on BeiGene

...this company is doing 1.29% worse in emissions than the industry average.

emission intelligence's platform recommendations for BeiGene

Bad news, BeiGene hasn't committed to SBTi goals yet

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch